Study tracking more than 173,000 British adults over a median 12.7 years finds consistent benefits across coronary artery disease, stroke and heart failure, regardless of genetic risk
People who drink two to three cups of unsweetened coffee a day have a 15 percent lower risk of developing cardiovascular disease compared with non-coffee drinkers, a new study has found. Notably, the cardiovascular benefits were observed regardless of an individual's genetic predisposition to the disease.
The findings come from an analysis of data from 173,614 participants in the UK Biobank, conducted by researcher Yang Miaomiao of the School of Public Health at Shenzhen University's Health Science Center and a research team led by Zhang Lei of the School of Public Health at Nantong University. The Korea Food Communication Forum (KOFRUM) released the results Friday.
The research team examined participants' coffee consumption habits and tracked whether they developed cardiovascular disease over the long term. The average age of participants was 55.7, and 131,247 of them — 75.6 percent of the total — reported drinking coffee regularly. The median follow-up period was 12.7 years, during which 18,659 participants were newly diagnosed with cardiovascular disease.
The most striking finding centered on two to three cups of coffee per day. People who drank that amount of unsweetened coffee had a 15 percent lower risk of cardiovascular disease than non-drinkers — an association that held even after accounting for variables such as age, sex and lifestyle habits.
Particularly notable was a U-shaped relationship between coffee consumption and cardiovascular disease risk. The findings suggest that health benefits do not increase indefinitely with greater intake; rather, the most favorable association was observed at a specific level of consumption.
The research team also broke down cardiovascular disease by subtype. Unsweetened coffee consumption showed broadly positive associations with the risk of developing coronary artery disease, stroke, heart failure and atrial fibrillation.
Genetic risk was another area of focus. The team used polygenic risk scores, which aggregate multiple genetic factors that can influence cardiovascular disease development. The association between coffee consumption and cardiovascular health was broadly similar among both high- and low-genetic-risk groups, suggesting that the relationship between coffee-drinking habits and cardiovascular disease risk may not be limited to people with particular genetic profiles.
Beyond caffeine, coffee contains a range of polyphenols and bioactive compounds, including chlorogenic acid. Previous research has examined the antioxidant and anti-inflammatory properties of these compounds and their relationship to vascular function and glucose metabolism. The new findings add to the case for further investigation into how coffee's bioactive components may relate to cardiovascular health.
However, the study was an observational analysis of the relationship between existing consumption habits and disease incidence — not a clinical trial in which participants were assigned to drink a set amount of coffee. It is therefore not possible to conclude that coffee directly prevents cardiovascular disease.
The study, titled "Association of unsweetened and sweetened coffee consumption with risk of cardiovascular disease: a prospective cohort study," was published in the June 2026 issue of the international journal Nutrition, Metabolism and Cardiovascular Diseases.
kty@heraldcorp.com